+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Medicine Market by Product Type (Diagnostics, Therapeutics), Technology (Bioinformatics, Digital Health & AI, Genomics & Proteomics), Application, End User - Global Forecast 2025-2030- Product Image
Personalized Medicine Market by Product Type (Diagnostics, Therapeutics), Technology (Bioinformatics, Digital Health & AI, Genomics & Proteomics), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Personalized Medicine Market by Product Type (Diagnostics, Therapeutics), Technology (Bioinformatics, Digital Health & AI, Genomics & Proteomics), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977907
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The personalized medicine market is rapidly redefining healthcare delivery by aligning prevention, diagnosis, and treatment to individual patient profiles. As patient expectations, stakeholder strategies, and digital innovation evolve, senior decision-makers face new opportunities and rising challenges while optimizing healthcare outcomes.

Market Snapshot: Personalized Medicine Market Size and Growth

The Personalized Medicine Market grew from USD 425.48 billion in 2024 to USD 466.84 billion in 2025. With a projected CAGR of 9.92%, the market is forecast to reach USD 750.69 billion by 2030. This expansion reflects substantial investments in technology, clinical adoption, and global research collaborations. Increasing uptake of biomarker-driven care and regulatory support for novel solutions are enhancing industry momentum across major regions and therapeutic segments.

Scope & Segmentation of the Personalized Medicine Market

Spanning diagnostics, therapeutics, enabling technologies, and applications, this report offers in-depth segmentation relevant to strategic planning and opportunity identification.

  • Product Types: Companion diagnostics, genetic testing, imaging diagnostics, molecular diagnostics, cell and gene therapies, immunotherapy, monoclonal antibodies, pharmaceuticals
  • Technologies: Bioinformatics, digital health and AI, genomics and proteomics platforms, pharmacogenomics
  • Applications: Cardiology (including arrhythmia, heart failure), endocrinology, infectious diseases (bacterial, viral), neurology (neurodegenerative, psychiatric), oncology (hematologic malignancies, solid tumors)
  • End Users: Academic and research institutes, diagnostic laboratories, hospitals and clinics
  • Geographic Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Analysis: Strategy review and trends for Abbott Laboratories, Agilent Technologies, AMGEN, BGI Genomics, Bio-Rad Laboratories, Bio‑Techne, Biogen, Danaher Corporation, Exact Sciences, GE Healthcare, Guardant Health, Illumina, Myriad Genetics, Novartis, Pfizer, QIAGEN, Roche, Siemens Healthcare, Thermo Fisher Scientific, PierianDx, CRISPR Therapeutics, bluebird bio, Vertex Pharmaceuticals

Key Takeaways for Senior Decision-Makers

  • Patient-centric care is increasingly incorporated into mainstream clinical workflows, supported by digital health and real-time analytics tools for treatment personalization.
  • Collaborative partnerships are accelerating innovation pipelines, with cross-sector alliances driving the development and deployment of novel diagnostics and therapeutics.
  • Value-based healthcare models are prompting providers and payers to adopt outcome-driven reimbursement strategies aligned with precision interventions.
  • Data standardization, privacy, reimbursement complexity, and ethical oversight remain primary challenges as the sector seeks greater integration and scalability.
  • Regional developments—including infrastructure modernization in Asia-Pacific and structured health technology assessment in Western Europe—impact adoption and scale across geographies.
  • Competition is intensifying as established industry leaders and emerging technology providers invest in automation, genomic data management, and advanced clinical decision support solutions.

Tariff Impact on Supply Chain and Pricing

Newly implemented United States tariffs on imported sequencing equipment, reagents, and consumables have reshaped supply chain strategies. Diagnostic laboratories and therapeutic developers are managing cost pressures by reevaluating procurement, increasing focus on domestic suppliers, and engaging in regional production expansion. The industry is responding by adopting resource-efficient innovations and strengthening supplier partnerships to address these complexities and maintain market competitiveness.

Methodology & Data Sources

This market research integrates primary stakeholder interviews with senior executives, laboratory leaders, and policymakers, alongside comprehensive secondary data analysis. Quantitative market trends were validated by reviewing investment analyses, clinical approvals, and independent data sources, ensuring robust and reliable insights for strategic planning.

Why This Report Matters for Decision-Makers

  • Gain clarity on the evolving competitive landscape, technology adoption, and growth drivers, enabling strategy development aligned with market forces.
  • Understand segmentation-specific opportunities and regional influences shaping personalized medicine adoption, commercialization, and long-term returns.
  • Inform procurement, investment, and partnership decisions with data-driven analysis designed to address regulatory, operational, and tariff-related risk.

Conclusion

The personalized medicine market presents dynamic opportunities and unique challenges for senior executives. Decision-makers equipped with advanced, segment-focused insights and actionable strategies are well positioned to drive innovation, secure market share, and elevate patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven genomic profiling in routine oncology treatment decision making workflows across healthcare networks
5.2. Expansion of telemedicine and digital health platforms enabling remote pharmacogenomic consultation and personalized dosing recommendations
5.3. Adoption of single-cell sequencing technologies to uncover patient-specific tumor heterogeneity patterns for targeted therapy optimization
5.4. Development of mRNA vaccine platforms tailored to individual neoantigen profiles for next-generation personalized cancer immunotherapy pipelines
5.5. Emergence of multiomics data integration platforms combining proteomics, metabolomics, and transcriptomics for precision diagnostics and treatment stratification
5.6. Regulatory frameworks evolving globally to support adaptive clinical trials driven by real-time biomarker feedback and patient stratification
5.7. Implementation of digital twin technology to simulate complex patient physiological responses to customized therapeutic regimens in silico
5.8. Advancements in CRISPR-based gene editing and delivery systems for personalized treatment of rare monogenic diseases
5.9. Growth of direct-to-consumer genetic testing services integrating AI-powered risk prediction and lifestyle modification recommendations
5.10. Strategic collaborations between pharmaceutical companies and digital health startups to co-develop personalized drug delivery and adherence monitoring devices
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Personalized Medicine Market, by Product Type
8.1. Introduction
8.2. Diagnostics
8.2.1. Companion Diagnostics
8.2.2. Genetic Testing
8.2.3. Imaging Diagnostics
8.2.4. Molecular Diagnostics
8.3. Therapeutics
8.3.1. Cell & Gene Therapy
8.3.2. Immunotherapy
8.3.3. Monoclonal Antibodies
8.3.4. Pharmaceuticals
9. Personalized Medicine Market, by Technology
9.1. Introduction
9.2. Bioinformatics
9.3. Digital Health & AI
9.4. Genomics & Proteomics
9.5. Pharmacogenomics
10. Personalized Medicine Market, by Application
10.1. Introduction
10.2. Cardiology
10.2.1. Arrhythmia
10.2.2. Heart Failure
10.3. Endocrinology
10.4. Infectious Diseases
10.4.1. Bacterial
10.4.2. Viral
10.5. Neurology
10.5.1. Neurodegenerative
10.5.2. Psychiatric
10.6. Oncology
10.6.1. Hematologic Malignancies
10.6.2. Solid Tumors
11. Personalized Medicine Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
12. Americas Personalized Medicine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Personalized Medicine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Personalized Medicine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Agilent Technologies, Inc.
15.3.3. AMGEN INC
15.3.4. BGI Genomics Co., Ltd.
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Bio-Techne Corporation
15.3.7. Biogen Inc
15.3.8. Danaher Corporation
15.3.9. Exact Sciences Corporation
15.3.10. GE Healthcare Technologies, Inc
15.3.11. Guardant Health, Inc.
15.3.12. Illumina, Inc.
15.3.13. Myriad Genetics, Inc.
15.3.14. Novartis AG
15.3.15. Pfizer Inc
15.3.16. QIAGEN N.V.
15.3.17. Roche Holding AG
15.3.18. Siemens Healthcare GmbH
15.3.19. Thermo Fisher Scientific Inc.
15.3.20. PierianDx, Inc.
15.3.21. CRISPR Therapeutics AG
15.3.22. bluebird bio, Inc.
15.3.23. Vertex Pharmaceuticals Incorporated
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PERSONALIZED MEDICINE MARKET: RESEARCHAI
FIGURE 24. PERSONALIZED MEDICINE MARKET: RESEARCHSTATISTICS
FIGURE 25. PERSONALIZED MEDICINE MARKET: RESEARCHCONTACTS
FIGURE 26. PERSONALIZED MEDICINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIGITAL HEALTH & AI, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIGITAL HEALTH & AI, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEURODEGENERATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEURODEGENERATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 136. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 137. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 144. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 145. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 146. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 147. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 149. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 150. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 151. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 268. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 269. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 270. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 271. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 272. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 273. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 286. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 287. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 288. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 289. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 290. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 291. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 292. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 293. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 318. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 319. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 320. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 321. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 326. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 327. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 328. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 329. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 330. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 331. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 332. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 333. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. SPAIN PERS

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Personalized Medicine market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AMGEN INC
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bio‑Techne Corporation
  • Biogen Inc
  • Danaher Corporation
  • Exact Sciences Corporation
  • GE Healthcare Technologies, Inc
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Novartis AG
  • Pfizer Inc
  • QIAGEN N.V.
  • Roche Holding AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • PierianDx, Inc.
  • CRISPR Therapeutics AG
  • bluebird bio, Inc.
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 466.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 750.69 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Personalized Medicine Software Market by Type (EHR Integration, Genomic Data Analysis, Patient Satisfaction & Risk Assessment), Application (Cardiology, Neurology, Oncology), Deployment Mode, End User - Global Forecast 2025-2030 - Product Image

Personalized Medicine Software Market by Type (EHR Integration, Genomic Data Analysis, Patient Satisfaction & Risk Assessment), Application (Cardiology, Neurology, Oncology), Deployment Mode, End User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Application (Early Detection, Treatment Selection, Monitoring), By Indication (Oncology, Neurology), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Application (Early Detection, Treatment Selection, Monitoring), By Indication (Oncology, Neurology), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Personalized Medicine Biomarkers - Global Strategic Business Report - Product Image

Personalized Medicine Biomarkers - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Hyper Personalized Medicines - Global Strategic Business Report - Product Image

Hyper Personalized Medicines - Global Strategic Business Report

  • Report
  • 390 Pages
  • Global
From

About the Personalized Medicine Market

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.